Exemestane in Post-Menopausal Women With NSCLC
Clinical trial NCT02666105 · COMPLETED
Trial details
- NCT number
- NCT02666105
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-27
- Primary completion
- 2022-02-28
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.